Table 3 Quantitation of anti-fVIII... | American Society of Hematology

Table 3

Quantitation of anti-fVIII antibody in healthy donors, inhibitor-negative hemophilia A patients, and commercial inhibitor-negative human plasma with less than 1% fVIII activity

Anti-fVIII Ab, nM	Healthy donor plasma, n = 150	Inhibitor-negative hemophilia A plasma
Anti-fVIII Ab, nM	Healthy donor plasma, n = 150	Hemophilia A subjects, n = 32	Commercial (< 1% fVIII activity), n = 7
0.1-0.9	2	1	0
1-10	2	8	0
11-20	0	2	0
21-50	0	0	0
51-100	0	0	1
101-200	0	0	1
> 200	0	0	0
Anti-fVIII Ab–positive	3%	34%	29%

Anti-fVIII Ab, nM	Healthy donor plasma, n = 150	Inhibitor-negative hemophilia A plasma
Anti-fVIII Ab, nM	Healthy donor plasma, n = 150	Hemophilia A subjects, n = 32	Commercial (< 1% fVIII activity), n = 7
0.1-0.9	2	1	0
1-10	2	8	0
11-20	0	2	0
21-50	0	0	0
51-100	0	0	1
101-200	0	0	1
> 200	0	0	0
Anti-fVIII Ab–positive	3%	34%	29%